Gofen & Glossberg LLC IL raised its holdings in UnitedHealth Group Inc (NYSE:UNH) by 1.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,689 shares of the healthcare conglomerate’s stock after purchasing an additional 70 shares during the period. Gofen & Glossberg LLC IL’s holdings in UnitedHealth Group were worth $1,019,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. North Star Investment Management Corp. purchased a new position in UnitedHealth Group during the third quarter valued at approximately $30,000. Griffin Asset Management Inc. purchased a new position in UnitedHealth Group during the second quarter valued at approximately $44,000. Coastal Capital Group Inc. purchased a new position in UnitedHealth Group during the second quarter valued at approximately $45,000. Capital Advisors Ltd. LLC grew its stake in UnitedHealth Group by 235.7% during the second quarter. Capital Advisors Ltd. LLC now owns 235 shares of the healthcare conglomerate’s stock valued at $57,000 after acquiring an additional 165 shares in the last quarter. Finally, Next Capital Management LLC purchased a new position in UnitedHealth Group during the second quarter valued at approximately $61,000. Hedge funds and other institutional investors own 85.66% of the company’s stock.
Several equities analysts recently commented on UNH shares. Jefferies Financial Group cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and reduced their price objective for the company from $300.00 to $235.00 in a research note on Thursday. Barclays set a $260.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a research note on Tuesday. Zacks Investment Research raised shares of UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price objective for the company in a research note on Monday, July 22nd. Cleveland Research reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 15th. Finally, Morgan Stanley reduced their price objective on shares of UnitedHealth Group from $298.00 to $294.00 and set an “overweight” rating for the company in a research note on Thursday, September 26th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $283.22.
Shares of UnitedHealth Group stock opened at $222.07 on Friday. UnitedHealth Group Inc has a 1 year low of $208.07 and a 1 year high of $287.94. The firm has a market cap of $210.45 billion, a PE ratio of 17.24, a PEG ratio of 1.17 and a beta of 0.60. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.67 and a quick ratio of 0.67. The company has a 50 day simple moving average of $227.16 and a two-hundred day simple moving average of $240.09.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.46 by $0.14. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The business had revenue of $60.60 billion during the quarter, compared to analyst estimates of $60.59 billion. During the same period in the previous year, the business posted $3.14 earnings per share. UnitedHealth Group’s revenue for the quarter was up 8.0% on a year-over-year basis. As a group, research analysts anticipate that UnitedHealth Group Inc will post 14.83 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a dividend of $1.08 per share. The ex-dividend date was Friday, September 13th. This represents a $4.32 annualized dividend and a yield of 1.95%. UnitedHealth Group’s payout ratio is presently 33.54%.
In other news, Director Richard T. Burke sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $246.40, for a total value of $1,232,000.00. Following the completion of the sale, the director now directly owns 187,979 shares in the company, valued at approximately $46,318,025.60. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director William C. Ballard, Jr. sold 12,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the completion of the sale, the director now owns 61,309 shares of the company’s stock, valued at $15,652,800.79. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 24,000 shares of company stock valued at $5,924,120. 0.87% of the stock is currently owned by company insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: What does cost of debt say about a company’s financial health?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.